Skip to main content

Table 3 Estimated prevalence of chronic HCV infection and estimated number of affected individuals, 2013–2014, Belgium

From: Low hepatitis C prevalence in Belgium: implications for treatment reimbursement and scale up

Demographic characteristic HCV chronic infection 2013–2014
Number in study sample Prevalence in Belgium Individuals in Belgium
% 95% CI n 95% CI
Sex Female 1 0.04 0.005–0.34 2280 280–18,950
Male 3 0.20 0.05–0.85 10,770 2500–46,130
Region Brussels-Capital 0 0 0–0.99 0 0–11,430
Flanders 4 0.21 0.07–0.66 13,300 4130–42,180
Wallonia 0 0 0–0.46 0 0–16,390
Age group (in years) < 20 1 0.08 0.01–0.54 1990 290–13,700
≥20 3 0.13 0.04–0.43 10,900 3220–36,790
  20–29 0 0 0–0.98 0 0–13,670
30–39 1 0.31 0.04–2.27 4490 600–32,890
40–49 1 0.13 0.02–1.14 2150 250–18,230
50–59 1 0.27 0.03–2.3 4180 490–35,130
60–69 0 0 0–2.07 0 0–24,980
70–79 0 0 0–4.51 0 0–36,840
≥80 0 0 0–3.66 0 0–21,480
All   4 0.12 0.03–0.41 13,320 3770–45,510
  1. Legend: HCV: hepatitis C virus, CI: confidence interval